ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings

Benzinga Earnings

08/07

ICU Medical Inc (NASDAQ:ICUI) on Thursday posted upbeat earnings for the second quarter.

The company reported quarterly earnings of $2.37 per share which beat the analyst consensus estimate of $1.91 per share. The company reported quarterly sales of $551.700 million which beat the analyst consensus estimate of $533.428 million.

ICU Medical raised its FY2026 adjusted EPS guidance from $7.75-$8.45 to $8.60-$9.00.

Vivek Jain, ICU Medical’s Chief Executive Officer, said, “Second quarter results were ahead of our expectations for Infusion Systems and generally in line with expectations for the remainder of the business.”

ICU Medical shares rose 4.8% to $174.28 in pre-market trading.

These analysts made changes to their price targets on ICU Medical following earnings announcement.

Needham analyst Mike Matson maintained the stock with a Buy and raised the price target from $165 to $187.
BTIG analyst Sam Eiber maintained the stock with a Buy and raised the price target from $170 to $200.

Considering buying ICUI stock? Here’s what analysts think:

Photo via Shutterstock

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2657561732"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2657561732\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2657561732?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-07 18:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2657561732","market":"hk","top_or_hot":-1,"title":"ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings","media":"Benzinga Earnings","content":"<html><body><p><strong>ICU Medical Inc</strong> (NASDAQ:ICUI) on Thursday posted upbeat earnings for the second quarter.</p>\n<p>The company reported quarterly earnings of $2.37 per share which beat the analyst consensus estimate of $1.91 per share. The company reported quarterly sales of $551.700 million which beat the analyst consensus estimate of $533.428 million.</p>\n<p>ICU Medical raised its FY2026 adjusted EPS guidance from $7.75-$8.45 to $8.60-$9.00.</p>\n<p>Vivek Jain, ICU Medical’s Chief Executive Officer, said, “Second quarter results were ahead of our expectations for Infusion Systems and generally in line with expectations for the remainder of the business.”</p>\n<p>ICU Medical shares rose 4.8% to $174.28 in pre-market trading.</p>\n<p>These analysts made changes to their price targets on ICU Medical following earnings announcement.</p>\n<ul>\n<li>Needham analyst Mike Matson maintained the stock with a Buy and raised the price target from $165 to $187.</li>\n<li>BTIG analyst Sam Eiber maintained the stock with a Buy and raised the price target from $170 to $200.</li>\n</ul>\n<p><strong>Considering buying ICUI stock? Here’s what analysts think:</strong></p>\n<figure><img decoding=\"async\" height=\"321\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/07064034/image-189-1024x321.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/07064034/image-189-1024x321.png 1024w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/07064034/image-189-300x94.png 300w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/07064034/image-189-768x241.png 768w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/07064034/image-189.png 1153w\" width=\"1024\"/></figure>\n<p><em>Photo via Shutterstock</em></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga Earnings </p>\n<p class=\"h-time smaller\">2026-08-07 18:43</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<html><body><p><strong>ICU Medical Inc</strong> (NASDAQ:ICUI) on Thursday posted upbeat earnings for the second quarter.</p>\n<p>The company reported quarterly earnings of $2.37 per share which beat the analyst consensus estimate of $1.91 per share. The company reported quarterly sales of $551.700 million which beat the analyst consensus estimate of $533.428 million.</p>\n<p>ICU Medical raised its FY2026 adjusted EPS guidance from $7.75-$8.45 to $8.60-$9.00.</p>\n<p>Vivek Jain, ICU Medical’s Chief Executive Officer, said, “Second quarter results were ahead of our expectations for Infusion Systems and generally in line with expectations for the remainder of the business.”</p>\n<p>ICU Medical shares rose 4.8% to $174.28 in pre-market trading.</p>\n<p>These analysts made changes to their price targets on ICU Medical following earnings announcement.</p>\n<ul>\n<li>Needham analyst Mike Matson maintained the stock with a Buy and raised the price target from $165 to $187.</li>\n<li>BTIG analyst Sam Eiber maintained the stock with a Buy and raised the price target from $170 to $200.</li>\n</ul>\n<p><strong>Considering buying ICUI stock? Here’s what analysts think:</strong></p>\n<figure><img decoding=\"async\" height=\"321\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/07064034/image-189-1024x321.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/07064034/image-189-1024x321.png 1024w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/07064034/image-189-300x94.png 300w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/07064034/image-189-768x241.png 768w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/08/07064034/image-189.png 1153w\" width=\"1024\"/></figure>\n<p><em>Photo via Shutterstock</em></p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ICUI","symbol_name":"ICU醫療","start_time":0,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/08/61032699/icu-medical-analysts-boost-their-forecasts-following-upbeat-q2-earnings","article_id":"2657561732","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2657561732","pubTimestamp":1786099412,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga Earnings","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":"\nICU Medical Inc (NASDAQ:ICUI) reported strong Q2 earnings of $2.37 per share and raised its FY2026 guidance. Analysts have increased price targets for the stock.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"ICUI":"ICU医疗","ICU":"SeaStar Medical Holding Corporation"},"translate_title":"第二季度盈利乐观后，ICU Medical 分析师上调了预测","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ICU":1.5,"ICUI":1.5},"content_text":"ICU Medical Inc (NASDAQ:ICUI) on Thursday posted upbeat earnings for the second quarter.\nThe company reported quarterly earnings of $2.37 per share which beat the analyst consensus estimate of $1.91 per share. The company reported quarterly sales of $551.700 million which beat the analyst consensus estimate of $533.428 million.\nICU Medical raised its FY2026 adjusted EPS guidance from $7.75-$8.45 to $8.60-$9.00.\nVivek Jain, ICU Medical’s Chief Executive Officer, said, 「Second quarter results were ahead of our expectations for Infusion Systems and generally in line with expectations for the remainder of the business.」\nICU Medical shares rose 4.8% to $174.28 in pre-market trading.\nThese analysts made changes to their price targets on ICU Medical following earnings announcement.\n\nNeedham analyst Mike Matson maintained the stock with a Buy and raised the price target from $165 to $187.\nBTIG analyst Sam Eiber maintained the stock with a Buy and raised the price target from $170 to $200.\n\nConsidering buying ICUI stock? Here’s what analysts think:\n\nPhoto via Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}